Table 2.
Blood concentrations for all groups at each follow-up period. Statistical significance and effect size for group-by-time interaction.
| Pre-T | Post-0 H | Post 2 H | P value | Eta2 | ||
|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||||
| CPK (U/L) | Control | 74.90 ± 17.21 | 74.10 ± 17.12 | 74.40 ± 16.57 | 0.425 | 0.065 |
| Thoracic | 72.00 ± 13.73 | 72.10 ± 16.00 | 71.10 ± 19.09 | |||
| Cervical | 65.10 ± 14.78 | 65.20 ± 16.29 | 68.10 ± 16.38 | |||
|
| ||||||
| LDH (U/L) | Control | 276.03 ± 57.30 | 283.43 ± 44.29 | 268.11 ± 47.02 | 0.167 | 0.112 |
| Thoracic | 297.20 ± 52.66 | 294.70 ± 52.69 | 289.80 ± 67.36 | |||
| Cervical | 275.90 ± 43.40 | 276.00 ± 28.20 | 302.80 ± 82.64 | |||
|
| ||||||
| Enolase (ng/mL) | Control | 9.48 ± 1.81 | 8.90 ± 1.24 | 8.86 ± 1.29 | 0.235 | 0.100 |
| Thoracic | 9.09 ± 1.50 | 9.52 ± 1.41 | 9.42 ± 2.95 | |||
| Cervical | 9.57 ± 3.26 | 9.23 ± 1.97 | 11.57 ± 6.17 | |||
|
| ||||||
| CPR (mg/L) | Control | 1.41 ± 1.00 | 1.61 ± 1.02 | 1.53 ± 1.19 | 0.486 | 0.058 |
| Thoracic | 0.56 ± 0.30 | 0.50 ± 0.27 | 0.50 ± 0.30 | |||
| Cervical | 1.48 ± 1.16 | 1.48 ± 1.22 | 1.47 ± 1.15 | |||
|
| ||||||
| Aldolase (U/L) | Control | 3.09 ± 1.60 | 3.36 ± 1.37 | 3.50 ± 1.57 | 0.859 | 0.019 |
| Thoracic | 3.10 ± 1.06 | 3.23 ± 1.25 | 3.17 ± 1.37 | |||
| Cervical | 3.13 ± 1.02 | 3.29 ± 0.90 | 3.63 ± 1.38 | |||
|
| ||||||
| Myoglobin (ng/mL) | Control | 50.76 ± 31.39 | 52.18 ± 23.63 | 70.20 ± 43.56 | 0.312 | 0.083 |
| Thoracic | 36.80 ± 10.81 | 38.30 ± 10.80 | 36.60 ± 10.60 | |||
| Cervical | 35.40 ± 20.87 | 35.80 ± 19.62 | 39.10 ± 22.19 | |||
Pre-T: pretreatment values; Post-0 H: values 0 H after intervention; Post-2 H: values 2 H after intervention; CPK: creatine phosphokinase; LDH: lactate dehydrogenase; CRP: C-reactive protein.